The first reported case of drug-induced hemolytic anemia caused by dimethyl fumarate in a patient with multiple sclerosis


Por: Quintanilla-Bordas, C, Castro-Izaguirre, E, Carcelen-Gadea, M and Marin, M

Publicada: 1 may 2019
Resumen:
BACKGROUND Drug-induced hemolytic anemia is a rare and potentially fatal complication of drug treatment. Specific laboratory tests are crucial to confirm the diagnosis. CASE REPORT A 38-year-old woman on treatment with dimethyl fumarate for multiple sclerosis presented with a 7-day history of weakness and fatigue. Laboratory tests revealed profound hemolytic anemia with hemoglobin levels of 4.7 g/dL (reference, 12.5-16.0), decreased haptoglobin, increased reticulocyte count, and increased indirect bilirubin. A first direct antiglobulin test was negative. The patient was started on prednisone 1 mg/kg/day, and dimethyl fumarate was withdrawn. A blood sample was drawn on Day 7 and sent to a reference laboratory. A direct antiglobulin test performed 7 days later was positive. Furthermore, an indirect antiglobulin test was positive only in the presence of the drug. RESULTS The patient did not receive a blood transfusion, recovered clinically during the following days, and was discharged on Day 7. On Day 36, the patient's RBCs had normalized. She was changed to another disease-modifying treatment for her multiple sclerosis, and at 10-month follow-up she remained stable without any notable adverse effects. CONCLUSION This case describes the first report of a dimethyl fumarate-induced hemolytic anemia. Laboratory results should always be interpreted within the clinical context. Specific laboratory expertise is often needed, given the complexity of the field.

Filiaciones:
Quintanilla-Bordas, C:
 Consorci Hosp Gen Univ Valencia, Dept Neurol, Neurol, Valencia, Spain

:
 Conselleria Sanitat, Ctr Transfus Comunidad Valenciana, Valencia, Spain

Carcelen-Gadea, M:
 Consorci Hosp Gen Univ Valencia, Dept Neurol, Neurol, Valencia, Spain

Marin, M:
 Consorci Hosp Gen Univ Valencia, Dept Hematol, Valencia, Spain
ISSN: 00411132





Transfusion
Editorial
WILEY-BLACKWELL, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Reino Unido
Tipo de documento: Article
Volumen: 59 Número: 5
Páginas: 1648-1650
WOS Id: 000467578600007
ID de PubMed: 30702749

MÉTRICAS